Advances in gene therapy for hematologic disease and considerations for transfusion medicine.

Reddy, Opal L; Savani, Bipin N; Stroncek, David F; Panch, Sandhya R

Reddy, Opal L; Savani, Bipin N; Stroncek, David F; Panch, Sandhya R.

Afiliación

Reddy OL; Center for Cellular Engineering, National institutes of Health, Clinical Center, Bethesda, Maryland.
Savani BN; Vanderbilt University Medical Center, Nashville, Tennessee.
Stroncek DF; Center for Cellular Engineering, National institutes of Health, Clinical Center, Bethesda, Maryland.
Panch SR; Center for Cellular Engineering, National institutes of Health, Clinical Center, Bethesda, Maryland. Electronic address: Sandhya.panch@nih.gov.

Semin Hematol ; 57(2): 83-91, 2020 04.

Article en En | MEDLINE | ID: mdl-32892847

Asunto(s)

Terapia Genética/métodos; Enfermedades Hematológicas/genética; Enfermedades Hematológicas/terapia; Medicina Transfusional/métodos; Humanos

Palabras clave

Blood utilization; CAR-T cells; CRISPR; Gene therapy; Hematologic disease; Transfusion medicine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Genética / Medicina Transfusional / Enfermedades Hematológicas Límite: Humans Idioma: En Revista: Semin Hematol Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google